Bill > S00893

This bill establishes new regulations for the use of antipsychotic medications in nursing homes, focusing on informed consent and patient protection. The legislation requires nursing homes and health care professionals to obtain written informed consent from residents or their legal representatives before administering antipsychotic medications, with some exceptions such as prior prescriptions, hospice care, and emergency situations. The informed consent process must include detailed disclosures about the medication's purpose, potential benefits, side effects, alternative treatments, and the resident's right to refuse or revoke consent. In emergency situations where an immediate threat exists, medication can be administered without prior consent, but the healthcare professional must document the reasons, dosage, and promptly notify the resident's representative. The bill also requires documentation of consent discussions and, when requested, notification of family members within 48 hours. The legislation aims to protect nursing home residents by ensuring they or their representatives are fully informed about antipsychotic medication treatments, while also providing flexibility for urgent medical needs. The law will take effect one year after becoming law, allowing time for nursing homes and healthcare providers to implement the new requirements.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S893